Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+7.05%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$25.9B
AUM Growth
+$1.75B
(+7.2%)
Cap. Flow
+$304M
Cap. Flow
% of AUM
1.17%
Top 10 Holdings %
Top 10 Hldgs %
23.48%
Holding
1,080
New
134
Increased
325
Reduced
445
Closed
139
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$172M |
| 2 |
Intel
INTC
|
$169M |
| 3 |
Amphenol
APH
|
$132M |
| 4 |
Intuit
INTU
|
$103M |
| 5 |
Southwest Airlines
LUV
|
$92.2M |
Top Sells
| 1 |
Fortinet
FTNT
|
$251M |
| 2 |
Constellation Energy
CEG
|
$237M |
| 3 |
Uber
UBER
|
$180M |
| 4 |
Mastercard
MA
|
$148M |
| 5 |
Exelon
EXC
|
$116M |
Sector Composition
| 1 | Technology | 30.45% |
| 2 | Financials | 14.25% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Industrials | 12.34% |
| 5 | Healthcare | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Vir Biotechnology
VIR
$717M
| $2.62M | 0.01% |
350,265
+33,473
| +11% | +$251K |
|
552
Vertiv
VRT
$46.9B
| $2.62M | 0.01% |
26,296
-10,654
| -29% | -$1.06M |
|
553
Cerence
CRNC
$402M
| $2.59M | 0.01% |
+823,428
| New | +$2.59M |
|
554
HarborOne Bancorp
HONE
$560M
| $2.59M | 0.01% |
199,702
+1,285
| +0.6% | +$16.7K |
|
555
BellRing Brands
BRBR
$4.54B
| $2.59M | 0.01% |
42,638
-11,134
| -21% | -$676K |
|
556
Mayville Engineering Co
MEC
$303M
| $2.57M | 0.01% |
122,055
+58,242
| +91% | +$1.23M |
|
557
Universal Display
OLED
$6.97B
| $2.57M | 0.01% |
12,254
+10,538
| +614% | +$2.21M |
|
558
Aldeyra Therapeutics
ALDX
$338M
| $2.57M | 0.01% |
476,949
+295,864
| +163% | +$1.59M |
|
559
Olin
OLN
$2.86B
| $2.56M | 0.01% |
53,296
+48,671
| +1,052% | +$2.34M |
|
560
Ecovyst
ECVT
$1.04B
| $2.55M | 0.01% |
372,049
-394,381
| -51% | -$2.7M |
|
561
TETRA Technologies
TTI
$622M
| $2.55M | 0.01% |
+821,305
| New | +$2.55M |
|
562
Skywest
SKYW
$4.54B
| $2.52M | 0.01% |
29,689
+10,539
| +55% | +$896K |
|
563
Cinemark Holdings
CNK
$3.09B
| $2.51M | 0.01% |
+90,210
| New | +$2.51M |
|
564
Pulmonx
LUNG
$71.3M
| $2.5M | 0.01% |
301,361
-188,926
| -39% | -$1.57M |
|
565
SelectQuote
SLQT
$346M
| $2.46M | 0.01% |
1,133,107
-154,589
| -12% | -$335K |
|
566
Ambarella
AMBA
$3.53B
| $2.45M | 0.01% |
43,420
-416
| -0.9% | -$23.5K |
|
567
Chemours
CC
$2.38B
| $2.45M | 0.01% |
+120,506
| New | +$2.45M |
|
568
Varex Imaging
VREX
$482M
| $2.41M | 0.01% |
+202,290
| New | +$2.41M |
|
569
CAVA Group
CAVA
$7.47B
| $2.39M | 0.01% |
19,333
-1,345
| -7% | -$167K |
|
570
Udemy
UDMY
$1.02B
| $2.37M | 0.01% |
318,507
-172,498
| -35% | -$1.28M |
|
571
Bioventus
BVS
$484M
| $2.34M | 0.01% |
195,608
-102,407
| -34% | -$1.22M |
|
572
Northfield Bancorp
NFBK
$494M
| $2.33M | 0.01% |
201,067
+66,003
| +49% | +$766K |
|
|
PSTX
573
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.32M | 0.01% |
811,512
-115,494
| -12% | -$330K |
|
574
DexCom
DXCM
$30.9B
| $2.32M | 0.01% |
34,609
+30,058
| +660% | +$2.02M |
|
575
Arcturus Therapeutics
ARCT
$475M
| $2.31M | 0.01% |
99,699
-637
| -0.6% | -$14.8K |
|